The emerging link between O-GlcNAcylation and neurological disorders

Area of Science:

• Neuroscience
• Biochemistry
• Cell Biology

Background:

• O-linked β-N-acetylglucosaminylation (O-GlcNAcylation) is a crucial post-translational modification regulating cellular processes.
• Its expression is elevated in the brain, involving enzymes O-linked N-acetylglucosaminyltransferase (OGT) and β-N-acetylglucosaminidase (OGA).
• O-GlcNAcylation is essential for normal neuronal function but its dysregulation is implicated in neurological disorders.

Purpose of the Study:

• To review the physiological and pathological roles of O-GlcNAcylation in the nervous system.
• To explore the therapeutic potential of modulating O-GlcNAcylation for neurological disorders.

Main Methods:

• Literature review of existing research on O-GlcNAcylation in the nervous system.
• Analysis of O-GlcNAcylation's involvement in neurodegenerative diseases and brain injury models.

Main Results:

• O-GlcNAcylation of key proteins like tau and amyloid-β influences their phosphorylation and aggregation.
• Increased O-GlcNAcylation, achieved pharmacologically, can prevent neuronal loss and ameliorate brain damage.
• O-GlcNAcylation is stress-sensitive and exhibits cytoprotective effects.

Conclusions:

• O-GlcNAcylation plays a dual role in neuronal health and disease pathogenesis.
• Modulating O-GlcNAcylation presents a promising therapeutic strategy for neurological disorders.
• Further research can build upon this understanding to develop targeted treatments.